Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
EU leaders seek climate deal, but are divided over costs
'Goodfellas' actor sues 'The Simpsons' for $250 mn
Mexico says mayor, wife were behind student-teacher disappearances
U.S. tightens Ebola monitoring for West African visitors
Palestinian driver rams Jerusalem station killing baby
At U.N., China asked to back human rights case against North Korea
Filling the space Between
Anyone whose last name is Rossevelt gets a RM295 stay in iconic New York hotel
Science Film Festival looks to the future
Copyright © 1995-2014 Star Publications (M) Bhd (Co No 10894-D)